Wall Street Journal quotes Bilus on case against pharmacists

Wall Street Journal quotes Bilus on case against pharmacists
Trials of Compounding Pharmacists Facing Murder Charges Draw Closer
January 4, 2017
Peter Loftus
The Wall Street Journal

Alexander (Sandy) Bilus, a partner in Saul Ewing’s practices in Commercial Litigation and White Collar and Government Litigation, shares his opinion in The Wall Street Journal on upcoming trials involving two pharmacists facing second-degree murder charges for the sale of a contaminated medication that caused outbreaks of fungal meningitis and numerous deaths. According to the article, the two pharmacists, who co-owned a now-closed compounding pharmacy, have been charged with violating the federal Racketeer Influenced and Corrupt Organizations act, including by allegedly committing the second-degree murder of 25 people who took the drug. They also face charges of mail fraud and bringing misbranded drugs into interstate commerce with the intent to defraud and mislead consumers. The pharmacists, Barry J. Cadden and Glenn Chin, have pleaded not guilty to all charges.
“It could be tough for prosecutors to convince the jury that Mr. Cadden knew what his subordinates were up to, and that ‘it was so dangerous it was reasonably certain to kill someone,’” said Sandy in the article. “That’s a pretty high standard to me.” 
Sandy also mentions that, “Even if the jury doesn’t accept the second-degree murder allegations, it could still find Mr. Cadden guilty of the racketeering charge based on other allegations such as mail fraud.” 
To read the full article, click here (subscription required).